Abstract
The induction of benoxaprofen (BNX) glucuronidation in rats by intragastric administration of three nitrogen heterocycles (quinoline, 2,2′-dipyridyl, or 1,7-phenanthroline at 75 mg/kg daily for 3 days) has been investigated. BNX was administered i.v. at a dose of 20 mg/kg to bile-cannulated rats that had been induced. Blood and bile were collected over 8 h. Liver tissues were also collected at the end of the 8-h study and used to examine conjugation activity of BNX by UDP-glucuronosyl transferases and cytochrome P-450 enzyme activities in vitro. Two methods were used to characterize the true metabolic formation rates of the labile benoxaprofen glucuronide conjugate in vitro, which gave comparable mean values forKM and Vmax. There appeared to be a trend of increase of theVmax of BNX glucuronidation in rat liver microsomes by all three nitrogen heterocycles; however, the induction was only significant with 1,7-phenanthroline.KM was not noticeably altered by any of the three inducers. No change of measured hepatic microsomal cytochrome P-450 activities in the rat was found. BNX glucuronidation in rats in vivo was increased by all three nitrogen heterocycles with 1,7-phenanthroline more effective than quinoline and 2,2′-dipyridyl. The use of nitrogen heterocycles provides a means to modulate exposure to labile, reactive acyl glucuronides in vivo without apparent changes in oxidative metabolism.
Footnotes
-
Send reprint requests to: Dr. Philip C. Smith, Division of Drug Delivery and Disposition, CB#7360, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7360. E-mail: pcs{at}emailunc.edu
-
↵1 Present address: CB#7360, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7360.
-
↵2 Present address: Research Triangle Institute, Research Triangle Park, NC 27709.
-
This study was supported by National Institutes of Health Grant GM41828.
- Abbreviations used are::
- UGT
- UDP-glucuronosyl transferase
- BNX
- benoxaprofen
- BNX-G
- benoxaprofen glucuronide conjugate
- CYP
- cytochrome P-450
- QO
- quinoline
- PH
- 1,7-phenanthroline
- DP
- 2,2′-dipyridyl
- TFA
- trifluoroacetic acid
- SA
- saccharic acid-1, 4-lactone
- PMSF
- phenylmethylsulfonyl fluoride
- AUC0→8hr
- area under the plasma concentration curve up to 8 h
- Ae,bile,0→8hr
- cumulative biliary excretion up to 8 h
- Clf,bile,app
- apparent biliary formation clearance of BNX-G
- Received April 26, 1999.
- Accepted August 19, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|